Učitavanje...

BI-15 RADIO- CHEMOTHERAPY IMPROVES SURVIVAL FOR IDH MUTANT, 1p19q-NON-CODELETED SECONDARY HIGH-GRADE-ASTROCYTOMA

OBJECTIVES: The RTOG 9402 trial reported an improved Outcome in IDH mutant and 1p19q-codeleted anaplastic oligodendroglial tumors after chemotherapy (CT) with radiotherapy (RT). We evaluated the efficacy of CT and RT in patients with IDH mutant, 1p19q-noncodeleted secondary high-grade astrocytoma (s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Neuro Oncol
Glavni autori: Juratli, Tareq, Geiger, Kathrin, Lautenschlaeger, Tim, Schackert, Gabriele, Krex, Dietmar
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217882/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou239.15
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!